Added by | mollevi |
---|---|
Group name | EquipeAM |
Item Type | Note |
Note | Pujol, Jean-Louis |
Date Added | 2018/11/14 - 12:43:03 |
Date Modified | 2018/11/14 - 12:43:03 |
Parent item | Safety and immunogenicity of the PRAME cancer immunotherapeutic in patients with resected non-small cell lung cancer: a phase I dose escalation study |